Literature DB >> 12361432

Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival.

Giorgio Ercolani1, Gian Luca Grazi, Matteo Ravaioli, Matteo Cescon, Andrea Gardini, Giovanni Varotti, Massimo Del Gaudio, Bruno Nardo, Antonino Cavallari.   

Abstract

HYPOTHESIS: Multiple and/or bilateral liver metastases are not absolute contraindications to surgical resection.
DESIGN: Retrospective analysis.
SETTING: University department of surgery and transplantation. PATIENTS AND INTERVENTION: A total of 245 curative liver resections for colorectal metastases were divided into 3 groups: M1, single lesions; M2, multiple unilobar; and M3, multiple bilobar. MAIN OUTCOME MEASURES: Univariate and multivariate analysis using several prognostic factors was performed to distinguish variables affecting long-term survival.
RESULTS: Overall operative mortality was 0.8%. Overall 5-year survival was 34%. On multivariate analysis, only the percentage of hepatic involvement by the tumor significantly affected prognosis. By replacing this variable with the total tumor volume, this latter variable was the only independent predictor of survival. Patients with multiple metastases and total tumor volume less than 125 cm(3) had a significantly better outcome than patients with single nodules and total tumor volume more than 380 cm( 3). Operative mortality and morbidity were comparable among groups M1, M2, and M3. The 5-year survival was 41%, 17%, and 34%, respectively (group M1 vs M2, P =.05; group M1 vs M3 and group M2 vs M3, not significant). The 5-year survival was 41% and 23% in patients with single and multiple lesions, respectively and was 35% and 32% in patients with unilobar and bilobar lesions, respectively.
CONCLUSIONS: A better outcome in patients with small single lesions was shown. In patients with multiple and/or bilateral metastases, an acceptable 5-year survival superior to 20% was obtained by surgical approach. The total volume of metastases, not number and location, seems to be the strongest predictor of survival.

Entities:  

Mesh:

Year:  2002        PMID: 12361432     DOI: 10.1001/archsurg.137.10.1187

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  18 in total

Review 1.  Current treatment for colorectal liver metastases.

Authors:  Evangelos P Misiakos; Nikolaos P Karidis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

2.  CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?

Authors:  Sheng-Xiang Rao; Doenja Mj Lambregts; Roald S Schnerr; Rianne Cj Beckers; Monique Maas; Fabrizio Albarello; Robert G Riedl; Cornelis Hc Dejong; Milou H Martens; Luc A Heijnen; Walter H Backes; Geerard L Beets; Meng-Su Zeng; Regina Gh Beets-Tan
Journal:  United European Gastroenterol J       Date:  2015-08-21       Impact factor: 4.623

3.  Long-term survival after repeat resections of metastases in liver, lung, and stomach from sigmoid colon cancer: report of a case.

Authors:  Fuyo Yoshimi; Yuji Asato; Akifumi Suzuki; Moriyuki Kiyoshima; Yasukazu Shioyama; Johji Imura; Masayuki Itabashi
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

4.  Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.

Authors:  Giovanni Brandi; Jody Corbelli; Francesco de Rosa; Stefania Di Girolamo; Ciro Longobardi; Valentina Agostini; Ingrid Garajová; Stefano La Rovere; Giorgio Ercolani; Gian Luca Grazi; Antonio Daniele Pinna; Guido Biasco
Journal:  Langenbecks Arch Surg       Date:  2012-06-19       Impact factor: 3.445

5.  Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm.

Authors:  Ruediger P Laubender; Julia Lynghjem; Melvin D'Anastasi; Volker Heinemann; Dominik P Modest; Ulrich R Mansmann; Ute Sartorius; Michael Schlichting; Anno Graser
Journal:  Eur Radiol       Date:  2014-05-10       Impact factor: 5.315

6.  Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome.

Authors:  Adriano Tocchi; Gianluca Mazzoni; Stefania Brozzetti; Michelangelo Miccini; Diletta Cassini; Elia Bettelli
Journal:  Int J Colorectal Dis       Date:  2004-04-22       Impact factor: 2.571

7.  Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer.

Authors:  Marcella Arru; Luca Aldrighetti; Renato Castoldi; Saverio Di Palo; Elena Orsenigo; Marco Stella; Carlo Pulitanò; Francesca Gavazzi; Gianfranco Ferla; Valerio Di Carlo; Carlo Staudacher
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

8.  Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.

Authors:  Srinevas K Reddy; Gloria Broadwater; Donna Niedzwiecki; Andrew S Barbas; Herbert I Hurwitz; Johanna C Bendell; Michael A Morse; Bryan M Clary
Journal:  J Gastrointest Surg       Date:  2008-08-07       Impact factor: 3.452

9.  The role of liver resections for metastases from lung carcinoma.

Authors:  Giorgio Ercolani; Matteo Ravaioli; Gian Luca Grazi; Matteo Cescon; Giovanni Varotti; Massimo Del Gaudio; Gaetano Vetrone; Matteo Zanello; Alfonso Principe; Antonio Daniele Pinna
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

10.  Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis.

Authors:  K A Paschos; N Bird
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.